Taiwan draws foreign biotech IPOs


Vibrant scene: Taiwan is home to the largest number of listed biotechnology companies in Asia with the sector expanding due to a well-educated workforce, historic appetite for high-tech industries and government support. – AFP

Singapore firm working on experimental cancer drugs plans listing by end-May

HONG KONG: A Singaporean biotechnology company working on experimental cancer drugs is listing in Taiwan, potentially opening the door for more foreign peers to go public on the island.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , IPO , cancer , drugs , Taiwan

   

Next In Business News

Smart Asia to issue 93.5mil shares, en route to ACE Market listing
Matrade to organise halal showcase in Dubai
Feytech inks underwriting deal with TA Securities, AmInvestment Bank
Ringgit extends gains to open higher against US$
Loan applications for property take a breather in Feb
Upsides on Bursa capped by negative global sentiment
Trading ideas: Maxis, Bank Islam, Malaysian Flour Mills, Menang, HeiTech Padu, Reservoir Link, MGRC, IGB REIT, Affin Bank and Excel Force
Keyfield FY23 earnings rise to RM105.5mil
Reservoir Link sub-unit bags RM22mil job
IGB-REIT net profit up 11.1% to RM99.61mil in 1Q

Others Also Read